Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis

American Journal of Clinical Pathology

Volumn 123, Issue 6, 2005, Pages 833-839

  Ni, Hongyu ^a,c   Barosi, Giovanni ^b,c   Rondelli, Damiano ^a,c   Huffman, Ronald ^a,c,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c MPD Research Consortium   (United States)

^d Cancer Center (M/C700)   (United States)

Author keywords

Bone marrow; Idiopathic myelofibrosis; Myeloproliferative disorders

Indexed keywords

RETICULIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MYELOID METAPLASIA; PRIORITY JOURNAL;

EID: 19644370622     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7A5JU9KJK89VQPH9     Document Type: Article

References (23)

1. Huffman R. Agnogenic myeloid metaplasia. In Huffman R, Benz E Jr, Shattil S, et al, eds. Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill Livingstone; 2000:1172-1188.
2. Schmitt A, Drouin A, Masse JM, et al. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis. Leuk Lymphoma. 2002;43:719-724.
3. Terui T, Niitsu Y, Mahara K, et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood. 1990;75:1540-1548.
4. Rameshwar P, Denny TN, Stein D, et al. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines: potential role for interleukin-1 and TGF-beta. J Immunol. 1994;153:2819-2830.
5. Douer D, Fabian l, Cline MJ. Circulating pluripotent haematopoietic cells in patients with myeloproliferative disorders. Br J Haematol. 1983;54:373-381.
6. Barosi G, Viarengo G, Pecci A, et al. Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. Blood. 2001;98:3249-3255.
7. Thiele J, Kvasnicka HM, Fisher R. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders: aids to diagnosis and classification. Ann Hematol. 1999;78:495-506.
8. Thiele J, Kvasnicka HM, Czieslick C. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue. Ann Hematol. 2002;81:86-89.
9. Barosi G, Ambrosetti A, Finelli C, et al. The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol. 1999;104:730-737.
10. Bauermeister DE. Quantitation of bone marrow reticulin: a normal range. Am J Clin Pathol. 1971;56:24-31.
11. Weibel ER. Point counting methods. In: Practical Methods for Biological Morphometry. London, England: Academic Press; 1979:101-161. Stereological Methods; vol 1.
12. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34+ cell count based on the ISHAGE guidelines. Cytometry. 1998;34:61-70.
13. Devine SM, Huffman R, Verma A, et al. Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood. 2002;99:2255-2258.
14. Barosi G. Myelofibrosis with myeloid metaplasia. Hematol Oncol Clin North Am. 2003;17:1211-1226.
15. Wolf BC, Neiman RS. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood. 1985;65:803-809.
16. Thiele J, Kvasnicka HM, Zankovich R, et al. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol. 2001;80:160-165.
17. Buhr T, Busche G, Choritz H, et al. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol. 2003;119:152-158.
18. Passamonti F, Vanelli L, Malabarba L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica. 2003;88:1123-1129.
19. Kirshner HP, Goldberg J, Landaw SA. The spleen as a site of colony-forming cell production in myelofibrosis. Proc Soc Exp Biol Med. 1980;165:279-282.
20. Wolf BC, Neiman RS. Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol. 1987;1:77-80.
21. Wang JC, Cheung CP, Ahmed F, et al. Circulating granulocyte and macrophage progenitor cells in primary and second myelofibrosis. Br J Haematol. 1983;54:301-307.
22. Liesveld JL, Winslow JM, Kempski MC, et al. Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components. Exp Hematol. 1991;19:63-70.
23. Guardiola P, Anderson JE, Bandini G, et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center collaborative study. Blood. 1999;93:2831-2838.